Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages

  Tinhofer, Ingeborg ^a   Hristozova, Tsvetana ^a   Stromberger, Carmen ^a   Keilhoiz, Ulrich ^a   Budach, Volker ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Circulating tumor cells; EGFR; Head and neck cancer; Pharmacodynamic biomarker; Radiotherapy

Indexed keywords

ABSOLUTE NUMBER; BASAL EXPRESSION; BLOOD VOLUMES; CETUXIMAB; CIRCULATING TUMOR CELLS; CIS-PLATIN; DEFINITIVE RADIOTHERAPY; EGFR; EPIDERMAL GROWTH FACTOR RECEPTORS; HEAD-AND-NECK CANCER; INDUCTION CHEMOTHERAPY; PERIPHERAL BLOOD; PHARMACODYNAMIC BIOMARKERS; PREDICTIVE VALUES; RADIATION-INDUCED; RADIOCHEMOTHERAPY; SIGNALLING PATHWAYS; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; TUMOR CELLS;

BIOMARKERS; BLOOD; CELLS; CHEMOTHERAPY; FLOW CYTOMETRY; INFORMATION DISSEMINATION; PHOSPHORYLATION;

RADIOTHERAPY;

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; FLOW CYTOMETRY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84863629688     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.009     Document Type: Article

References (20)

1. M. Cristofanilli, G.T. Budd, and M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
2. D.C. Danila, G. Heller, and G.A. Gignac Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer Clin Cancer Res 13 2007 7053 7058
3. Cohen SJ PC, Iannotti N, Saidman BH, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-3221.
4. T. Hristozova, R. Konschak, and C. Stromberger The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN) Ann Oncol 22 2011 1878 1885
5. H.I. Scher, X. Jia, and J.S. de Bono Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data Lancet Oncol 10 2009 233 239
6. K. Pachmann, R. Dengler, and K. Lobodasch An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer J Cancer Res Clin Oncol 134 2008 59 65
7. A.M. Egloff, and J.R. Grandis Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer Semin Oncol 35 2008 286 297
8. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
9. J.B. Vermorken, R. Mesia, and F. Rivera Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
10. K. Camphausen, M.A. Moses, and W.D. Beecken Radiation therapy to a primary tumor accelerates metastatic growth in mice Cancer Res 61 2001 2207 2211
11. S. Biswas, M. Guix, and C. Rinehart Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression J Clin Invest 117 2007 1305 1313
12. A.M. Sieuwerts, J. Kraan, and J. Bolt-de Vries Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR Breast Cancer Res Treat 118 2009 455 468
13. C.G. Rao, D. Chianese, and G.V. Doyle Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors Int J Oncol 27 2005 49 57
14. C. Holz, F. Niehr, and M. Boyko Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells Radiother Oncol 2011
15. A.C. Pickhard, J. Margraf, and A. Knopf Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways BMC Cancer 11 2011 388
16. A. Diaz Miqueli, J. Rolff, and M. Lemm Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies Br J Cancer 100 2009 950 958
17. G. Kallergi, S. Agelaki, and A. Kalykaki Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients Breast Cancer Res 10 2008 R80
18. D.F. Hayes, T.M. Walker, and B. Singh Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer Int J Oncol 21 2002 1111 1117
19. J.S. de Bono, G. Attard, and A. Adjei Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor Clin Cancer Res 13 2007 3611 3616
20. V. Budach, M. Stuschke, and W. Budach Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial J Clin Oncol 23 2005 1125 1135